We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.5B
AUM Growth
+$1B
Cap. Flow
+$580M
Cap. Flow %
5.53%
Top 10 Hldgs %
19.46%
Holding
2,367
New
170
Increased
1,265
Reduced
735
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 6.58%
2 Financials 4.76%
3 Healthcare 4.4%
4 Consumer Discretionary 3.56%
5 Industrials 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UQM
2201
DELISTED
UQM Technologies, Inc.
UQM
$34K ﹤0.01%
25,869
PDLI
2202
DELISTED
PDL BioPharma, Inc.
PDLI
$33K ﹤0.01%
12,704
-4,773
-27% -$11.7K
SDR
2203
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$33K ﹤0.01%
25,850
+3,336
+15% +$5.21K
NVAX icon
2204
Novavax
NVAX
$1.31B
$32K ﹤0.01%
864
+53
+7% +$1.49K
VIVS
2205
VivoSim Labs
VIVS
$1.23M
$30K ﹤0.01%
109
-15
-12% -$4.51K
TURN
2206
DELISTED
180 Degree Capital
TURN
$28K ﹤0.01%
4,308
ATHX
2207
DELISTED
Athersys, Inc. Common Stock
ATHX
$27K ﹤0.01%
512
NAVB
2208
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$27K ﹤0.01%
5,905
SIOX
2209
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$26K ﹤0.01%
+1,350
New +$24.6K
TGB
2210
Trekor Metals
TGB
$3.23B
$25K ﹤0.01%
+31,350
New +$26.2K
AGEN
2211
Agenus
AGEN
$307M
$24K ﹤0.01%
+577
New +$22.7K
FCSC
2212
DELISTED
Fibrocell Science Inc.
FCSC
$24K ﹤0.01%
10,085
-9,481
-48% -$20.5K
ALIM
2213
DELISTED
Alimera Sciences
ALIM
$23K ﹤0.01%
1,587
HOV icon
2214
Hovnanian Enterprises
HOV
$805M
$20K ﹤0.01%
490
-24
-5% -$973
APRN
2215
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$20K ﹤0.01%
63
+5
+9% +$2.19K
GENE
2216
DELISTED
Genetic Technologies Ltd.
GENE
$19K ﹤0.01%
850
UPL
2217
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$14K ﹤0.01%
12,872
+2,300
+22% +$3.41K
PTN
2218
Palatin Technologies
PTN
$13.2M
$12K ﹤0.01%
9
-1
-10% -$1.24K
FTF.RT
2219
DELISTED
Franklin Limited Duration Income Trust Rights (expiring October 18, 2018)
FTF.RT
$2K ﹤0.01%
+20,159
New +$3.89K
HMNY
2220
DELISTED
Helios and Matheson Analytics Inc.
HMNY
$1K ﹤0.01%
+48,582
New +$486K
AAOI icon
2221
Applied Optoelectronics
AAOI
$11.4B
-8,306
Closed -$373K
AAXJ icon
2222
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
-7,099
Closed -$509K
AEIS icon
2223
Advanced Energy
AEIS
$13.1B
-4,032
Closed -$234K
AIA icon
2224
iShares Asia 50 ETF
AIA
$4.95B
-102,996
Closed -$6.47M
ALE
2225
DELISTED
Allete
ALE
-2,710
Closed -$210K

Similar funds

Cambridge Investment Research Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Cambridge Investment Research Advisors held 2,367 positions worth $10.5B, up 11% from $9.47B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors deployed $580M of net new capital in Q3 2018, opening 170 new positions and adding to 1,265 existing holdings. Its largest new stake was State Street SPDR S&P Retail ETF: 299,035 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 5.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg International Treasury Bond ETF, an estimated $29.1M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2018 buy was State Street SPDR S&P Retail ETF: 299,035 shares worth $15.3M.
  • Cambridge Investment Research Advisors added most to iShares Russell 2000 ETF in Q3 2018, an estimated $34.8M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2018 reduction was State Street SPDR Bloomberg International Treasury Bond ETF, cutting an estimated $29.1M.
  • Cambridge Investment Research Advisors fully exited iShares International Treasury Bond ETF in Q3 2018, selling an estimated $12.2M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $10.5B portfolio in Q3 2018.
  • Cambridge Investment Research Advisors opened 170 new positions and closed 136 in Q3 2018.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $10.5B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2018, filed 2 Nov 2018.